← Back to Search

Behavioural Intervention

Expanding Communication and Language Generated in Conversation Treatment for Aphasia

N/A

Recruiting

Led By Marion Leaman, PhD

Research Sponsored by University of Kansas Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline; weeks 1-2 (pre-treatment); weeks 13-14 (post-treatment); weeks 19-20 (6-week maintenance)

Awards & highlights

Study Summary

This trial aims to test a new therapy called 'Expanding Communication and Language Generated in Conversation Treatment' (ECoLoGiC Treatment) to help improve language skills in people with aphasia after a

Who is the study for?

This trial is for English-speaking adults aged 18-85 with moderate to severe aphasia from a left hemisphere stroke at least 6 months ago. They must be able to see and hear (with aids if necessary), produce phrases, understand simple language, and read at least single words. Right-handed individuals before their stroke are eligible.Check my eligibility

What is being tested?

The ECoLoGiC Treatment aims to improve conversation skills in people with aphasia. It involves twice-weekly sessions over 10 weeks where patients practice talking with therapists who guide them progressively. Additionally, family members receive training to support the patient's communication at home.See study design

What are the potential side effects?

Since this therapy focuses on speech-language pathology rather than medication or surgery, traditional side effects are not expected. However, participants may experience fatigue or frustration during the learning process.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline; weeks 1-2 (pre-treatment); weeks 13-14 (post-treatment); weeks 19-20 (6-week maintenance)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline; weeks 1-2 (pre-treatment); weeks 13-14 (post-treatment); weeks 19-20 (6-week maintenance)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; weeks 1-2 (pre-treatment); weeks 13-14 (post-treatment); weeks 19-20 (6-week maintenance) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change on American Speech Language Hearing Association: Functional Assessment of Communication Skills for Adults (Family-Reported Outcome Measure)

Change on Assessment for Living with Aphasia - 2 (Patient-Reported Outcome Measure)

Change on Communicative Success of verbal and nonverbal communication in Conversation

+3 more

Secondary outcome measures

Change in Communicative Success of verbal and nonverbal communication in Monologue

Change in Complete Utterance for sentence production in Monologue

Change in Complete Utterances for sentence production in Conversation

+16 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Expanding Communication and Language Generated in Conversation TreatmentExperimental Treatment1 Intervention

Participants will complete 20 one-hour therapy sessions over 10 weeks with an experienced, trained, and licensed speech-language pathologist delivering Expanding Communication and Language Generated in Conversation Therapy, following the therapy protocol. Sessions will take place through casual conversational interactions, with incremental problem-solving and communication support by the speech-language pathologist.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor

463 Previous Clinical Trials

169,255 Total Patients Enrolled

National Center for Advancing Translational Sciences (NCATS)NIH

322 Previous Clinical Trials

401,748 Total Patients Enrolled

2 Trials studying Aphasia

1,505 Patients Enrolled for Aphasia

Marion Leaman, PhDPrincipal InvestigatorUniversity of Kansas Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals meet the eligibility criteria to participate in this research endeavor?

"Individuals with aphasia aged between 18 and 85 are eligible for participation in the trial, with approximately 15 positions available."

Answered by AI

Are individuals above the age of 60 eligible for enrollment in this research trial?

"Patients aged between 18 and 85 are eligible to participate in this research study. It is important to note that there are a total of 19 ongoing trials dedicated to individuals under the age of 18, while there are currently 107 active trials specifically catering to those over the age of 65."

Answered by AI

What is the total number of participants involved in this clinical research study?

"Indeed, as per clinicaltrials.gov information, this medical investigation is actively seeking individuals. The trial was first listed on the 3rd of January, 2024 and last revised on the 28th of March, 2024. Enrollment targets to recruit a total of 15 participants at one designated site."

Answered by AI

Are there any current opportunities for potential participants to enroll in this trial?

"Indeed, the information provided on clinicaltrials.gov confirms that this trial is actively seeking participants. The initial posting of the clinical trial was on January 3rd, 2024 and the most recent update occurred on March 28th, 2024. This study aims to recruit a total of 15 patients from one specific site."

Answered by AI

What is the primary objective of this clinical trial?

"The primary objective of this investigation, evaluated over distinct temporal segments (Baseline; Pre-Treatment Weeks 1-2; Post-Treatment Weeks 13-14; and 6-Week Maintenance Weeks 19-20), aims to assess alterations in Communication Activities of Daily Living - 3. The secondary endpoints include modifications in Subject-Verb-(Object) sentence structure during Monologue, with an emphasis on changes between the post-treatment phase versus pre-treatment as well as the maintenance phase compared to pre-treatment. Additionally, adjustments in grammaticality within Conversational contexts will be analyzed by comparing scores obtained post-treatment against pre-t"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ECoLoGiC Speech Therapy for Everyday Communication in Aphasia

2024. "ECoLoGiC Speech Therapy for Everyday Communication in Aphasia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06132464.

All > Aphasia > Kansas City